Exosomes containing miR-216a-5p inhibit the inflammatory response induced by recombinant Tp17 by targeting the TLR4–MyD88 pathway.491 Melphalan, a genotoxic agent, can enhance the ability of multiple myeloma (MM) cells to release exosomes in MM. The gene discussed is MYD88; the disease is Miyoshi myopathy.